Skip to main content

Table 3 Comparisons of oncological outcomes according to location of previously reported 102 LGMS cases and the present case

From: Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature review

  Head and neck Trunk Extremity Total
Oncological outcome
 CDF 35/48 (72.9%) 15/23 (65.2%) 14/18 (77.8%) 64/89 (71.9%)
 NED 11/48 (22.9%) 5/23 (21.7%) 3/18 (16.7%) 19/89 (21.4%)
 AWD 0/48 (0%) 1/23 (4.4%) 0/18 (0%) 1/89 (1.1%)
 DOD 2/48 (4.2%) 2/23 (8.7%) 1/18 (5.5%) 5/89 (5.6%)
Local recurrence
 Yes 13/49 (26.5%) 6/22 (27.3%) 5/19 (26.3%) 24/90 (26.7%)
 No 36/49 (73.5%) 16/22 (72.7%) 14/19 (73.7%) 66/90 (73.3%)
Distant metastasis
 Yes 1/49 (2.0%) 2/23 (8.7%) 1/19 (5.3%) 4/91 (4.4%)
 No 48/49 (98.0%) 21/23 (91.3%) 18/19 (94.7%) 87/91 (95.6%)
  1. LGMS Low-grade myofibroblastic sarcoma, CDF Continuous disease free, NED No evidence of disease, AWD Alive with disease, DOD Death of disease